Hypoxia induces ERα down-regulation which inhibits its genomic activity and binds to chromatin, and can modulate the efficacy of endocrine therapies by selectively sustaining the expression of a subset of ERα responsive genes whose expression is associated with a poor overall survival of patients with ERα (+) breast cancers. Here, ESR1 is linked to breast cancer.